Who Is the Ideal Candidate for Hair Microneedling in Wakad?
November 6, 2026
No Comments
Read More »
Written by: Dr. Kiran Chotaliya Editorial Team · Reviewed by: Dr. Kiran Chotaliya, M.D. Dermatologist & Chief Hair transplant Surgeon · Hairfree & Hairgrow Clinics, India · Updated Oct 2026
This case study documents the 5-month treatment journey of a 25-year-old female patient with localized alopecia areata. At baseline, the patient presented with clearly visible patchy areas of scalp hair loss with significant scalp exposure. Serial photographs document progressive changes at 1 month, 2 months, 3 months, and 5 months, with increasing hair regrowth and improved scalp coverage over time. Pasted markdown
The patient was treated with Kenacort Injection (triamcinolone corticosteroid injection) as advised by the treating dermatologist. For accuracy, Kenacort injections can also be used medically for conditions such as hypertrophic scars, but in this case the treatment is being documented for alopecia areata, not for a hypertrophic scar.
Patient Consent Notice
This case study has been published with the patient’s informed consent for educational and informational purposes. Appropriate measures have been taken to maintain patient privacy while presenting the scalp condition, treatment process, and documented progress.
Individual alopecia areata outcomes vary. Hair regrowth can depend on the extent and activity of the condition, duration of hair loss, response to corticosteroid treatment, recurrence, and individual biological factors. The outcome shown in this case should not be considered a guarantee of similar results for every patient. Pasted markdown
Patient Details | Information |
Age | 25 years |
Gender | Female |
Condition | Alopecia Areata |
Pattern | Localized patchy hair loss |
Affected Area | Scalp |
Treatment | Kenacort Injection |
Treatment Type | Intralesional corticosteroid treatment |
Documented Follow-Up | 1, 2, 3 and 5 months |
Latest Documented Progress | 5 months |
The patient’s alopecia areata was assessed based on the location, appearance, and extent of the localized patches.
Clinical evaluation focused on:
Serial photographs were used to document the visible treatment response over a five-month period. Pasted markdown
Following clinical assessment, the patient was advised Kenacort Injection treatment for the alopecia-affected scalp areas.
Kenacort contains triamcinolone, a corticosteroid that may be administered intralesionally by a dermatologist in selected alopecia areata cases. The dosage, concentration, injection interval, and number of treatment sessions should always be determined according to the treating dermatologist’s clinical assessment.
The treatment goals included:
The photographic follow-up was documented at baseline and at approximately 1, 2, 3, and 5 months. Pasted markdown
|
Parameter
|
No. of Grafts
|
Details
|
|---|---|---|
|
|
530
|
For natural hairline
|
|
|
2480
|
Mid scalp coverage
|
|
|
3010
|
|
Kenacort Injection was administered to the affected alopecia areata patches according to the dermatologist’s treatment plan.
The injection is directed carefully into selected areas of the affected scalp. Treatment is generally performed in a controlled manner, with the amount and spacing of injections individualized according to the size and location of the patches.
Regular follow-up was used to assess:
The photographic sequence indicates that hair regrowth occurred gradually over several months rather than immediately. Pasted markdown
At baseline, the patient had clearly visible localized bald patches with significant scalp exposure. Pasted markdown
The affected scalp showed:
This stage served as the baseline against which later treatment progress was compared.
At the 1-month follow-up after Kenacort Injection treatment, the alopecia patches remained clearly visible, but early short hairs appeared to be developing in portions of the affected scalp.
Observed changes included:
This remained an early treatment stage, and the visible response did not represent the final outcome. Pasted markdown
At approximately 2 months, developing hair growth became more apparent within previously sparse areas.
Compared with the earlier stage:
The regrowing hairs remained relatively immature and varied in thickness and distribution. Pasted markdown
By the 3-month follow-up, further visible improvement was documented.
The affected patches showed:
This stage showed progressive regrowth, although continued improvement was still expected. Pasted markdown
At the 5-month follow-up, the photographs demonstrate a marked improvement compared with the baseline condition.
Visible changes included:
The five-month stage represents the latest documented follow-up for this patient rather than a guaranteed permanent final result. Pasted markdown
The documented treatment journey shows a progressive response following the Kenacort Injection treatment program:
Before Treatment: Clearly visible localized alopecia patches with significant scalp exposure
1 Month: Early fine hair growth with patches still clearly visible
2 Months: Developing regrowth and improving coverage
3 Months: Progressive increase in visible hair and reduced scalp exposure
5 Months: Significant improvement in hair coverage and reduced prominence of the affected patches
The photographic record demonstrates a gradual improvement over the documented five-month period. Pasted markdown
Following Kenacort Injection treatment, the patient should continue dermatologist-directed follow-up and scalp care.
Recommended maintenance may include:
Long-term follow-up helps determine whether further treatment is necessary and whether regrowth remains stable. Pasted markdown
The patient was treated with Kenacort Injection, an intralesional corticosteroid treatment administered according to the dermatologist’s assessment.
Kenacort contains triamcinolone, a corticosteroid. Intralesional corticosteroid injections may be used by dermatologists for selected conditions, including localized alopecia areata and hypertrophic scars, although the technique, dose, and treatment plan differ according to the condition being treated.
Early short hairs were visible during the initial follow-up period, with progressively better coverage documented at 2, 3, and 5 months.
Dr. Kiran Chotaliya is a leading hair transplant surgeon in Pune, specializing in advanced techniques like FUE and FUT for natural, lasting results. His expertise and patient-centered care ensure successful hair restoration with exceptional outcomes.
© 2026 Developed & Handle By Dr. Kiran Chotaliya Clinic Team
© 2026 Developed & Handle By Dr. Kiran Chotaliya Clinic Team
